Skip to content

A prospective, multicenter, randomized controlled clinical study of equal space replacement method in laparoscopic inguinal incarcerated hernia surgery

A prospective, multicenter, randomized controlled clinical study of equal space replacement method in laparoscopic inguinal incarcerated hernia surgery

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089372
Enrollment
Unknown
Registered
2024-09-06
Start date
2024-03-20
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

incarcerated hernia

Interventions

Experimental group: Equal space replacement method for treating incarcerated hernia contents:Equal space replacement method
Control group: Traditional method also includes incarcerated hernia contents:Traditional method

Sponsors

Nanchong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.According to ASA's evaluation criteria, the physical condition is Grade I to Grade II, with no obvious underlying heart or lung diseases. Currently, it is also believed that the comorbidities of Grade III patients are stable for more than 3 months; 2.Assess tolerance for laparoscopic surgery; 3.The surgical time should not exceed 3 hours; 4.The patient is informed and signs a surgical consent form.

Exclusion criteria

Exclusion criteria: 1.Those with severe illnesses such as heart function level III or above, large amounts of ascites, lower limb mobility disorders, etc. that affect their physical activity, and those with combined illnesses that affect their normal diet and work; 2.Patients with signs of peritonitis and severe organic liver and kidney diseases; 3.Patients with concomitant malignant tumor diseases; 4.Contraindications to surgical treatment.

Design outcomes

Primary

MeasureTime frame
Incarcerated small intestine injury;infection;recurrence;

Secondary

MeasureTime frame
hospitalization costs;pain;second operation;

Countries

China

Contacts

Public ContactBinyu luo

Nanchong Central Hospital

luobinyu2014@126.com+86 159 8481 6908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026